Literature DB >> 20362271

Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record.

Marylyn D Ritchie1, Joshua C Denny, Dana C Crawford, Andrea H Ramirez, Justin B Weiner, Jill M Pulley, Melissa A Basford, Kristin Brown-Gentry, Jeffrey R Balser, Daniel R Masys, Jonathan L Haines, Dan M Roden.   

Abstract

Large-scale DNA databanks linked to electronic medical record (EMR) systems have been proposed as an approach for rapidly generating large, diverse cohorts for discovery and replication of genotype-phenotype associations. However, the extent to which such resources are capable of delivering on this promise is unknown. We studied whether an EMR-linked DNA biorepository can be used to detect known genotype-phenotype associations for five diseases. Twenty-one SNPs previously implicated as common variants predisposing to atrial fibrillation, Crohn disease, multiple sclerosis, rheumatoid arthritis, or type 2 diabetes were successfully genotyped in 9483 samples accrued over 4 mo into BioVU, the Vanderbilt University Medical Center DNA biobank. Previously reported odds ratios (OR(PR)) ranged from 1.14 to 2.36. For each phenotype, natural language processing techniques and billing-code queries were used to identify cases (n = 70-698) and controls (n = 808-3818) from deidentified health records. Each of the 21 tests of association yielded point estimates in the expected direction. Previous genotype-phenotype associations were replicated (p < 0.05) in 8/14 cases when the OR(PR) was > 1.25, and in 0/7 with lower OR(PR). Statistically significant associations were detected in all analyses that were adequately powered. In each of the five diseases studied, at least one previously reported association was replicated. These data demonstrate that phenotypes representing clinical diagnoses can be extracted from EMR systems, and they support the use of DNA resources coupled to EMR systems as tools for rapid generation of large data sets required for replication of associations found in research cohorts and for discovery in genome science. (c) 2010 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20362271      PMCID: PMC2850440          DOI: 10.1016/j.ajhg.2010.03.003

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  A haplotype map of the human genome.

Authors: 
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

Review 2.  The genome-enabled electronic medical record.

Authors:  M A Hoffman
Journal:  J Biomed Inform       Date:  2006-03-15       Impact factor: 6.317

3.  Development and evaluation of a clinical note section header terminology.

Authors:  Joshua C Denny; Randolph A Miller; Kevin B Johnson; Anderson Spickard
Journal:  AMIA Annu Symp Proc       Date:  2008-11-06

4.  Comparing genetic ancestry and self-described race in african americans born in the United States and in Africa.

Authors:  Rona Yaeger; Alexa Avila-Bront; Kazeem Abdul; Patricia C Nolan; Victor R Grann; Mark G Birchette; Shweta Choudhry; Esteban G Burchard; Kenneth B Beckman; Prakash Gorroochurn; Elad Ziv; Nathan S Consedine; Andrew K Joe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-06       Impact factor: 4.254

5.  Use of an electronic medical record for the identification of research subjects with diabetes mellitus.

Authors:  Russell A Wilke; Richard L Berg; Peggy Peissig; Terrie Kitchner; Bozana Sijercic; Catherine A McCarty; Daniel J McCarty
Journal:  Clin Med Res       Date:  2007-03

6.  Supporting communication in an integrated patient record system.

Authors:  Dario A Giuse
Journal:  AMIA Annu Symp Proc       Date:  2003

7.  Computerized physician order entry of medications and clinical decision support can improve problem list documentation compliance.

Authors:  William L Galanter; Daniel B Hier; Chiang Jao; David Sarne
Journal:  Int J Med Inform       Date:  2008-07-02       Impact factor: 4.046

8.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

9.  Association of chromosome 9p21 SNPs with cardiovascular phenotypes in morbid obesity using electronic health record data.

Authors:  G Craig Wood; Christopher D Still; Xin Chu; Meghan Susek; Robert Erdman; Christina Hartman; Stephanie Yeager; Mary Ann Blosky; Wanda Krum; David J Carey; Kimberly A Skelding; Peter Benotti; Walter F Stewart; Glenn S Gerhard
Journal:  Genomic Med       Date:  2008-07-26

10.  Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.

Authors:  Eleftheria Zeggini; Michael N Weedon; Cecilia M Lindgren; Timothy M Frayling; Katherine S Elliott; Hana Lango; Nicholas J Timpson; John R B Perry; Nigel W Rayner; Rachel M Freathy; Jeffrey C Barrett; Beverley Shields; Andrew P Morris; Sian Ellard; Christopher J Groves; Lorna W Harries; Jonathan L Marchini; Katharine R Owen; Beatrice Knight; Lon R Cardon; Mark Walker; Graham A Hitman; Andrew D Morris; Alex S F Doney; Mark I McCarthy; Andrew T Hattersley
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

View more
  205 in total

1.  Using Electronic Health Records To Generate Phenotypes For Research.

Authors:  Sarah A Pendergrass; Dana C Crawford
Journal:  Curr Protoc Hum Genet       Date:  2018-12-05

2.  Evolving research and stakeholder perspectives on pharmacogenomics.

Authors:  Amber L Beitelshees; David L Veenstra
Journal:  JAMA       Date:  2011-09-21       Impact factor: 56.272

3.  A translational engine at the national scale: informatics for integrating biology and the bedside.

Authors:  Isaac S Kohane; Susanne E Churchill; Shawn N Murphy
Journal:  J Am Med Inform Assoc       Date:  2011-11-10       Impact factor: 4.497

4.  Association of direct-to-consumer genome-wide disease risk estimates and self-reported disease.

Authors:  Cinnamon S Bloss; Eric J Topol; Nicholas J Schork
Journal:  Genet Epidemiol       Date:  2011-11-29       Impact factor: 2.135

5.  An analytical approach to characterize morbidity profile dissimilarity between distinct cohorts using electronic medical records.

Authors:  Jonathan S Schildcrout; Melissa A Basford; Jill M Pulley; Daniel R Masys; Dan M Roden; Deede Wang; Christopher G Chute; Iftikhar J Kullo; David Carrell; Peggy Peissig; Abel Kho; Joshua C Denny
Journal:  J Biomed Inform       Date:  2010-08-03       Impact factor: 6.317

6.  A common 5'-UTR variant in MATE2-K is associated with poor response to metformin.

Authors:  J H Choi; S W Yee; A H Ramirez; K M Morrissey; G H Jang; P J Joski; J A Mefford; S E Hesselson; A Schlessinger; G Jenkins; R A Castro; S J Johns; D Stryke; A Sali; T E Ferrin; J S Witte; P-Y Kwok; D M Roden; R A Wilke; C A McCarty; R L Davis; K M Giacomini
Journal:  Clin Pharmacol Ther       Date:  2011-09-28       Impact factor: 6.875

7.  Enhancing uterine fibroid research through utilization of biorepositories linked to electronic medical record data.

Authors:  Lani Feingold-Link; Todd L Edwards; Sarah Jones; Katherine E Hartmann; Digna R Velez Edwards
Journal:  J Womens Health (Larchmt)       Date:  2014-12       Impact factor: 2.681

Review 8.  The intelligent use and clinical benefits of electronic medical records in multiple sclerosis.

Authors:  Mary F Davis; Jonathan L Haines
Journal:  Expert Rev Clin Immunol       Date:  2014-12-11       Impact factor: 4.473

9.  A natural language processing algorithm to define a venous thromboembolism phenotype.

Authors:  Eugenia R McPeek Hinz; Lisa Bastarache; Joshua C Denny
Journal:  AMIA Annu Symp Proc       Date:  2013-11-16

10.  Characterization of statin dose response in electronic medical records.

Authors:  W-Q Wei; Q Feng; L Jiang; M S Waitara; O F Iwuchukwu; D M Roden; M Jiang; H Xu; R M Krauss; J I Rotter; D A Nickerson; R L Davis; R L Berg; P L Peissig; C A McCarty; R A Wilke; J C Denny
Journal:  Clin Pharmacol Ther       Date:  2013-10-04       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.